Results

Total Results: 892 records

Showing results for "end stage renal".

521. STATISTICAL BRIEF #404: Expenditures for Hypertension among Adults Age 18 and Older, 2010: Estimates for the U.S. Civilian Noninstitutionalized Population
     meps.ahrq.gov/data_files/publications/st404/stat404.shtml
     April 01, 2013 - insurance plan for the elderly, persons receiving Social Security disability payments, and persons with end-stage … renal disease.

522. STATISTICAL BRIEF #306: Average Annual Health Care Use and Expenditures for Kidney Disease among Adults 18 and Older, U.S. Civilian Noninstitutionalized Population, 2003-2007
     meps.ahrq.gov/data_files/publications/st306/stat306.shtml
     December 01, 2010 - insurance plan for the elderly, persons receiving Social Security disability payments, and persons with end-stage … renal disease.

523. STATISTICAL BRIEF #505: Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2015
     meps.ahrq.gov/data_files/publications/st505/stat505.shtml
     November 01, 2017 - for persons age 65 and older, persons receiving Social Security disability payments, and persons with end-stage … renal disease.

524. STATISTICAL BRIEF #440: Expenditures for Treatment of Mental Health Disorders among Children, Ages 5-17, 2009-2011: Estimates for the U.S. Civilian Noninstitutionalized Population
     meps.ahrq.gov/data_files/publications/st440/stat440.shtml
     June 01, 2014 - insurance plan for the elderly, persons receiving Social Security disability payments, and persons with end-stage … renal disease.

525. Slow Down: Right Drug, Wrong Formulation | PSNet
     psnet.ahrq.gov/web-mm/slow-down-right-drug-wrong-formulation
     October 13, 2018 - WebM&M Cases Overdose of Gabapentin and Oxycodone in a Patient with End-Stage … Renal Disease: A Case for Appropriate Interruptive Drug-Disease Alerts.

526. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49522/psn-pdf
     November 01, 2006 - The Case A 55-year-old woman with end stage renal disease requiring hemodialysis and coronary artery … Hour Prior to Surgical Incision Prophylactic Antibiotics Discontinued Within 24 Hours After Surgery End

527. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - failure, chronic renal failure, or end-stage renal disease. 22-25 Some of these patient groups have … impairment, or severe renal impairment not undergoing dialysis and patients receiving dialysis? … impairment, severe renal impairment, and renal replacement therapy (KQ 8) Special Populations (Timing … impairment, severe renal impairment, renal replacement therapy • Animal studies/models • Children … CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

528. Spotlight: Overdiagnosis and Delay: Challenges in Sepsis Diagnosis | PSNet
     psnet.ahrq.gov/web-mm/spotlight-overdiagnosis-and-delay-challenges-sepsis-diagnosis
     October 28, 2020 - In the end, clinicians realized that the patient had initially been misdiagnosed with sepsis and that … organ dysfunction, such as hypotension, elevated lactate, respiratory failure, altered mental status, renal … the patient described had laboratory evidence of inflammation (elevated white blood cell count) and end-organ … When patients present with circulatory shock or signs of end-organ dysfunction, empiric antibiotics are

529. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - in 2-3 doses; Extended- release, 100-200 mg/day RA: Delayed- release, 100-200 mg/day in 3- 4 Renal … impairment(CrCl >25 mL/min) max 150 mg/day; Moderate renal impairment (CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal endpoint or serious liver AEs. … update 9/16/02 Pain reduction 2 placebo controlled trials provided pain intensity at baseline and end

530. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Page 32, line 45: Missing “placebo” from the end of the first sentence. … Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal … Public Comment #3 (APA) Introduction p. 4 table disulfiram Suggest changing "at the acetaldehyde stage

531. THE HCUP NATIONWIDE READMISSIONS DATABASE (NRD), 2013
     hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2013.jsp
     January 01, 2013 - Medicare patients younger than 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS). … software packages that perform calculations for numerous statistics arising from the stratified, single-stage … Medicare patients under the age of 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS).

532. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49843/psn-pdf
     October 01, 2018 - In the end, clinicians realized that the patient had initially been misdiagnosed with sepsis and that … organ dysfunction, such as hypotension, elevated lactate, respiratory failure, altered mental status, renal … the patient described had laboratory evidence of inflammation (elevated white blood cell count) and end-organ … When patients present with circulatory shock or signs of end-organ dysfunction, empiric antibiotics

533. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated … Many surrogate/intermediate end points have not been adequately validated. … Just because there is enough information to pool a myriad of intermediate end points does not mean that … This completes the topic refinement project and sets the stage for the next phase, in which the key questions

534. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

535. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
     March 01, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

536. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - What are the harms of treatment of early-stage or screening-detected prostate cancer? … Surveillance, Epidemiology, and End Results (SEER) program ( n =25,900) of men 65 to 80 years of age … comorbid conditions (diabetes, cardiovascular disease, respiratory disease, gastrointestinal disease, renal … 1: 29%  Stage 2: 40%  Stage 3: 31%  PSA < 10 µg/L: 22% PSA 11–29 µg/L: 28% PSA > 30 µg/L: 23% PSA unknown … prostate-specific antigen; RCT = randomized, controlled trial; SEER = Surveillance, Epidemiology, and End

537. e3iVR: Conference on Ethics in Investigational and Interventional Uses of Immersive VR - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
     January 01, 2017 - Results: By the end of Day 2, the group of stakeholder representatives and subject matter experts produced … These talks set the stage for development of guidelines that address the needs of these priority populations … reality include but are not limited to (i) the training of health professionals (e.g., percutaneous renal … If recognition of biases and defective perceptions in VR does not occur, we could end up increasing

538. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

539. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

540. In Conversation With… Sharon K. Inouye, MD, MPH | PSNet
     psnet.ahrq.gov/perspective/conversation-sharon-k-inouye-md-mph
     December 01, 2012 - tried to get them to share what they were using with me because I really viewed that as a means to an end … delirium, some of them say things like delirium following alcohol withdrawal, or delirium following renal … They're a little hyponatremic, going into renal failure, and on medications that maybe the doctor has … brain function [ 5 ]), it is worth thinking about delirium as an "acute brain injury" similar to other end-organ … As with these other important end-organ injuries, delirium is a clinical event for which prevention and